Bennett Pharmaceuticals Industry is a 100% Greek company, founded in 2005, and operates within the pharmaceutical and manufacturing industries. The company's activities span the entire spectrum of the pharmaceutical sector, encompassing the production of high-quality original and generic formulations. Their commitment to Research & Development, Innovation, and the integration of new technologies has positioned Bennett as the fastest growing company in the pharmaceutical market. Their focus on delivering quality and effective medicines, with a patient-centric approach, underpins their objective of identifying therapeutic solutions based on innovative ideas and state-of-the-art technologies. Bennett's pharmaceutical portfolio covers vital therapeutic categories including Cardiology, Psychiatry, Endocrinology, Pulmonology, Neurology, among others. Furthermore, the company has diversified its operations to include over-the-counter (OTC) products, medical devices, and nutritional supplements. Despite not having publicly disclosed their most recent investment details, Bennett Pharmaceuticals Industry has demonstrated its forward-thinking approach and potential for growth in the pharmaceutical industry, making it a company to watch.
There is no investment information
No recent news or press coverage available for Bennett Pharmaceutical industry.